

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by symbiont of host defense response (GO:0052509) | 5.26338719 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 5.26338719 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.26338719 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.26338719 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.26338719 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 5.26338719 |
| 7 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.78203479 |
| 8 | response to pheromone (GO:0019236) | 4.71698333 |
| 9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.69532339 |
| 10 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 4.26452119 |
| 11 | indole-containing compound catabolic process (GO:0042436) | 4.19061017 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 4.19061017 |
| 13 | tryptophan catabolic process (GO:0006569) | 4.19061017 |
| 14 | tryptophan metabolic process (GO:0006568) | 4.06944356 |
| 15 | macrophage activation involved in immune response (GO:0002281) | 3.93403545 |
| 16 | positive regulation of interferon-alpha production (GO:0032727) | 3.77727439 |
| 17 | indolalkylamine metabolic process (GO:0006586) | 3.63732376 |
| 18 | regulation of germinal center formation (GO:0002634) | 3.58039197 |
| 19 | regulation of interferon-alpha production (GO:0032647) | 3.55469921 |
| 20 | neutrophil activation involved in immune response (GO:0002283) | 3.55328221 |
| 21 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.55229284 |
| 22 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.49994828 |
| 23 | neural tube formation (GO:0001841) | 3.49543562 |
| 24 | intraciliary transport (GO:0042073) | 3.44238221 |
| 25 | detection of molecule of bacterial origin (GO:0032490) | 3.42311024 |
| 26 | regulation of cholesterol storage (GO:0010885) | 3.41846773 |
| 27 | response to host immune response (GO:0052572) | 3.39473641 |
| 28 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.39473641 |
| 29 | low-density lipoprotein particle clearance (GO:0034383) | 3.38854282 |
| 30 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.27636720 |
| 31 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.26944429 |
| 32 | cell wall macromolecule metabolic process (GO:0044036) | 3.26819442 |
| 33 | regulation of hypersensitivity (GO:0002883) | 3.25612988 |
| 34 | apoptotic cell clearance (GO:0043277) | 3.22628374 |
| 35 | kynurenine metabolic process (GO:0070189) | 3.21598747 |
| 36 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.21494892 |
| 37 | response to host (GO:0075136) | 3.21494892 |
| 38 | response to host defenses (GO:0052200) | 3.21494892 |
| 39 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.17740517 |
| 40 | positive regulation of mast cell degranulation (GO:0043306) | 3.17740517 |
| 41 | prostate gland growth (GO:0060736) | 3.13135725 |
| 42 | microglial cell activation (GO:0001774) | 3.09084343 |
| 43 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.07874416 |
| 44 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 3.07619335 |
| 45 | GPI anchor metabolic process (GO:0006505) | 3.05212284 |
| 46 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.05043501 |
| 47 | phospholipid homeostasis (GO:0055091) | 3.04048131 |
| 48 | mitochondrial DNA replication (GO:0006264) | 3.03359382 |
| 49 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.00764989 |
| 50 | protein carboxylation (GO:0018214) | 3.00764989 |
| 51 | positive regulation of mast cell activation (GO:0033005) | 2.98200867 |
| 52 | I-kappaB phosphorylation (GO:0007252) | 2.97949145 |
| 53 | macrophage activation (GO:0042116) | 2.97089970 |
| 54 | cell wall macromolecule catabolic process (GO:0016998) | 2.95418815 |
| 55 | lipoprotein transport (GO:0042953) | 2.88023044 |
| 56 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.86766495 |
| 57 | positive regulation of antigen processing and presentation (GO:0002579) | 2.86662809 |
| 58 | adenosine metabolic process (GO:0046085) | 2.86598654 |
| 59 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.86472098 |
| 60 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.86472098 |
| 61 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 2.85966458 |
| 62 | plasma lipoprotein particle clearance (GO:0034381) | 2.85781852 |
| 63 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.85224875 |
| 64 | cell adhesion mediated by integrin (GO:0033627) | 2.83645517 |
| 65 | limb bud formation (GO:0060174) | 2.80185784 |
| 66 | aggressive behavior (GO:0002118) | 2.80042998 |
| 67 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.78430958 |
| 68 | negative regulation of lipid storage (GO:0010888) | 2.74054019 |
| 69 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.72076622 |
| 70 | vitamin biosynthetic process (GO:0009110) | 2.71954640 |
| 71 | piRNA metabolic process (GO:0034587) | 2.71232207 |
| 72 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.70823462 |
| 73 | pinocytosis (GO:0006907) | 2.70439220 |
| 74 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.70117684 |
| 75 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.69639109 |
| 76 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.69331766 |
| 77 | hyaluronan catabolic process (GO:0030214) | 2.68051478 |
| 78 | behavioral response to nicotine (GO:0035095) | 2.67797888 |
| 79 | cellular response to ethanol (GO:0071361) | 2.67038960 |
| 80 | positive regulation of p38MAPK cascade (GO:1900745) | 2.65808307 |
| 81 | GPI anchor biosynthetic process (GO:0006506) | 2.64777989 |
| 82 | mannose metabolic process (GO:0006013) | 2.63258051 |
| 83 | phospholipid efflux (GO:0033700) | 2.61178793 |
| 84 | epithelial cilium movement (GO:0003351) | 2.60311992 |
| 85 | positive regulation of interferon-beta production (GO:0032728) | 2.60210021 |
| 86 | L-ascorbic acid metabolic process (GO:0019852) | 2.59478047 |
| 87 | protein localization to cilium (GO:0061512) | 2.59200383 |
| 88 | negative regulation of granulocyte differentiation (GO:0030853) | 2.59038706 |
| 89 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.58543351 |
| 90 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.58235465 |
| 91 | detection of external biotic stimulus (GO:0098581) | 2.57544741 |
| 92 | benzene-containing compound metabolic process (GO:0042537) | 2.56510899 |
| 93 | transepithelial transport (GO:0070633) | 2.55822226 |
| 94 | neutrophil activation (GO:0042119) | 2.54853342 |
| 95 | synapsis (GO:0007129) | 2.53940433 |
| 96 | regulation of meiosis I (GO:0060631) | 2.53578381 |
| 97 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.53457627 |
| 98 | alpha-linolenic acid metabolic process (GO:0036109) | 2.53425544 |
| 99 | photoreceptor cell maintenance (GO:0045494) | 2.53276147 |
| 100 | myeloid cell activation involved in immune response (GO:0002275) | 2.53210352 |
| 101 | cell differentiation involved in metanephros development (GO:0072202) | 2.53141900 |
| 102 | immunoglobulin mediated immune response (GO:0016064) | 2.52985100 |
| 103 | respiratory burst (GO:0045730) | 2.52402688 |
| 104 | granulocyte activation (GO:0036230) | 2.52166474 |
| 105 | response to peptidoglycan (GO:0032494) | 2.51832912 |
| 106 | centriole replication (GO:0007099) | 2.51349316 |
| 107 | protein-lipid complex assembly (GO:0065005) | 2.49550718 |
| 108 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.49079719 |
| 109 | detection of biotic stimulus (GO:0009595) | 2.48609681 |
| 110 | valine metabolic process (GO:0006573) | 2.48359520 |
| 111 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.47663001 |
| 112 | response to muramyl dipeptide (GO:0032495) | 2.47301549 |
| 113 | cilium organization (GO:0044782) | 2.47080826 |
| 114 | kidney morphogenesis (GO:0060993) | 2.47044601 |
| 115 | fucose catabolic process (GO:0019317) | 2.46922024 |
| 116 | L-fucose metabolic process (GO:0042354) | 2.46922024 |
| 117 | L-fucose catabolic process (GO:0042355) | 2.46922024 |
| 118 | aromatic amino acid family catabolic process (GO:0009074) | 2.46726406 |
| 119 | platelet dense granule organization (GO:0060155) | 2.46252305 |
| 120 | plasma lipoprotein particle assembly (GO:0034377) | 2.46005425 |
| 121 | nonmotile primary cilium assembly (GO:0035058) | 2.45784128 |
| 122 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.44862161 |
| 123 | positive regulation of hemostasis (GO:1900048) | 2.44708484 |
| 124 | positive regulation of blood coagulation (GO:0030194) | 2.44708484 |
| 125 | complement activation, alternative pathway (GO:0006957) | 2.44607341 |
| 126 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.44583631 |
| 127 | lipoprotein metabolic process (GO:0042157) | 2.44084426 |
| 128 | regulation of antigen processing and presentation (GO:0002577) | 2.43416780 |
| 129 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.42913941 |
| 130 | regulation of cilium movement (GO:0003352) | 2.42602273 |
| 131 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.42487420 |
| 132 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.41171214 |
| 133 | regulation of mononuclear cell migration (GO:0071675) | 2.41038306 |
| 134 | indole-containing compound metabolic process (GO:0042430) | 2.40791144 |
| 135 | cilium assembly (GO:0042384) | 2.40433149 |
| 136 | regulation of integrin activation (GO:0033623) | 2.40122231 |
| 137 | amine catabolic process (GO:0009310) | 2.40022326 |
| 138 | cellular biogenic amine catabolic process (GO:0042402) | 2.40022326 |
| 139 | low-density lipoprotein particle remodeling (GO:0034374) | 2.39368658 |
| 140 | positive regulation of prostaglandin secretion (GO:0032308) | 2.38206669 |
| 141 | positive regulation of chemokine secretion (GO:0090197) | 2.38125331 |
| 142 | basic amino acid transport (GO:0015802) | 2.38094892 |
| 143 | urea cycle (GO:0000050) | 2.37645884 |
| 144 | urea metabolic process (GO:0019627) | 2.37645884 |
| 145 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.37472070 |
| 146 | branched-chain amino acid catabolic process (GO:0009083) | 2.37393326 |
| 147 | positive regulation of coagulation (GO:0050820) | 2.36846369 |
| 148 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.36697455 |
| 149 | regulation of gamma-delta T cell activation (GO:0046643) | 2.36626070 |
| 150 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.35789477 |
| 151 | somite development (GO:0061053) | 2.35615430 |
| 152 | ubiquinone biosynthetic process (GO:0006744) | 2.35596476 |
| 153 | C-terminal protein lipidation (GO:0006501) | 2.35118663 |
| 154 | negative regulation of mast cell activation (GO:0033004) | 2.35020937 |
| 155 | S-adenosylmethionine metabolic process (GO:0046500) | 2.34328296 |
| 156 | positive regulation of phagocytosis (GO:0050766) | 2.34074889 |
| 157 | axoneme assembly (GO:0035082) | 2.33450379 |
| 158 | cholesterol efflux (GO:0033344) | 2.33388054 |
| 159 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.33387085 |
| 160 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.32160973 |
| 161 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.31823244 |
| 162 | positive regulation of B cell differentiation (GO:0045579) | 2.30080868 |
| 163 | positive regulation of glycolytic process (GO:0045821) | 2.29801766 |
| 164 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.29188034 |
| 165 | wound healing, spreading of epidermal cells (GO:0035313) | 2.28400736 |
| 166 | modification by symbiont of host morphology or physiology (GO:0044003) | 2.27855297 |
| 167 | transcytosis (GO:0045056) | 2.27112762 |
| 168 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.27068242 |
| 169 | regulation of mast cell activation (GO:0033003) | 2.26410307 |
| 170 | oligosaccharide catabolic process (GO:0009313) | 2.26122586 |
| 171 | negative regulation of interleukin-12 production (GO:0032695) | 2.26106437 |
| 172 | DNA double-strand break processing (GO:0000729) | 2.25900742 |
| 173 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.24975842 |
| 174 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.24639652 |
| 175 | cilium morphogenesis (GO:0060271) | 2.23087609 |
| 176 | reverse cholesterol transport (GO:0043691) | 2.23056370 |
| 177 | cytokine secretion (GO:0050663) | 2.22087839 |
| 178 | regulation of protein activation cascade (GO:2000257) | 2.22055545 |
| 179 | cilium movement (GO:0003341) | 2.21898294 |
| 180 | NAD biosynthetic process (GO:0009435) | 2.21770634 |
| 181 | response to nitrosative stress (GO:0051409) | 2.21394980 |
| 182 | xenobiotic catabolic process (GO:0042178) | 2.21277441 |
| 183 | regulation of prostaglandin secretion (GO:0032306) | 2.20259496 |
| 184 | response to laminar fluid shear stress (GO:0034616) | 2.20136141 |
| 185 | response to vitamin E (GO:0033197) | 2.19921920 |
| 186 | seminiferous tubule development (GO:0072520) | 2.19895672 |
| 187 | regulation of phagocytosis (GO:0050764) | 2.19195189 |
| 188 | vitamin D metabolic process (GO:0042359) | 2.18159685 |
| 189 | quinone biosynthetic process (GO:1901663) | 2.18125389 |
| 190 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.17901523 |
| 191 | natural killer cell activation involved in immune response (GO:0002323) | 2.17585271 |
| 192 | keratan sulfate catabolic process (GO:0042340) | 2.17567486 |
| 193 | aromatic amino acid family metabolic process (GO:0009072) | 2.17565869 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.66264676 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.39502044 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.90462497 |
| 4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.57128350 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.42858322 |
| 6 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.27393610 |
| 7 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.11150875 |
| 8 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.08479798 |
| 9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.95516714 |
| 10 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.93671839 |
| 11 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.93418475 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.91508418 |
| 13 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.84227417 |
| 14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.82389998 |
| 15 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.79533983 |
| 16 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.79208894 |
| 17 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.77230661 |
| 18 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.72217383 |
| 19 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.66540299 |
| 20 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.52775014 |
| 21 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.51141506 |
| 22 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.50230460 |
| 23 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.50140145 |
| 24 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.41949451 |
| 25 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.35367304 |
| 26 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.32677114 |
| 27 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.31567776 |
| 28 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.30980255 |
| 29 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.29676126 |
| 30 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.26029803 |
| 31 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.18550624 |
| 32 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.18536372 |
| 33 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.18500299 |
| 34 | VDR_22108803_ChIP-Seq_LS180_Human | 2.18380112 |
| 35 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.10693858 |
| 36 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.09956119 |
| 37 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.05805845 |
| 38 | FUS_26573619_Chip-Seq_HEK293_Human | 2.05348454 |
| 39 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.01745546 |
| 40 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.97229545 |
| 41 | EWS_26573619_Chip-Seq_HEK293_Human | 1.95798186 |
| 42 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.95594417 |
| 43 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.93142722 |
| 44 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.84686935 |
| 45 | P300_19829295_ChIP-Seq_ESCs_Human | 1.83826921 |
| 46 | GATA1_22025678_ChIP-Seq_K562_Human | 1.78826274 |
| 47 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.77892176 |
| 48 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.73203236 |
| 49 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.72220956 |
| 50 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.71431348 |
| 51 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.70924402 |
| 52 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.69429686 |
| 53 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.67546562 |
| 54 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.65261594 |
| 55 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.59526575 |
| 56 | SPI1_23127762_ChIP-Seq_K562_Human | 1.58057518 |
| 57 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.56947647 |
| 58 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.55496710 |
| 59 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.55283577 |
| 60 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.55100255 |
| 61 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.54510649 |
| 62 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.54047034 |
| 63 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.53724589 |
| 64 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.53582744 |
| 65 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.52694263 |
| 66 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.52263701 |
| 67 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.51983760 |
| 68 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.51839871 |
| 69 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.50947590 |
| 70 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.48764425 |
| 71 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.48606527 |
| 72 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.47581574 |
| 73 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.47581574 |
| 74 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.45990632 |
| 75 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.44789979 |
| 76 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.43858839 |
| 77 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.43641315 |
| 78 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.41212602 |
| 79 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.41055910 |
| 80 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.40903847 |
| 81 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.39782356 |
| 82 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.39782356 |
| 83 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.39566748 |
| 84 | MAF_26560356_Chip-Seq_TH1_Human | 1.39446488 |
| 85 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.38540425 |
| 86 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.38450504 |
| 87 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.37620117 |
| 88 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.37605463 |
| 89 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.37417064 |
| 90 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.37188516 |
| 91 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.36856803 |
| 92 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.36671914 |
| 93 | STAT3_23295773_ChIP-Seq_U87_Human | 1.35863881 |
| 94 | AR_25329375_ChIP-Seq_VCAP_Human | 1.35845180 |
| 95 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.35469748 |
| 96 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.35284779 |
| 97 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.34716437 |
| 98 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.34665479 |
| 99 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.34423700 |
| 100 | TCF4_23295773_ChIP-Seq_U87_Human | 1.34301072 |
| 101 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.34290660 |
| 102 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.33609784 |
| 103 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.31776816 |
| 104 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.31550708 |
| 105 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.31182868 |
| 106 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.30972924 |
| 107 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.30147440 |
| 108 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.30062144 |
| 109 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.30008206 |
| 110 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29645777 |
| 111 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.29336219 |
| 112 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.28676492 |
| 113 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.27124527 |
| 114 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.27103816 |
| 115 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.27103816 |
| 116 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.26519962 |
| 117 | * MYB_26560356_Chip-Seq_TH2_Human | 1.26320104 |
| 118 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25601053 |
| 119 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.25249629 |
| 120 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.25179264 |
| 121 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.24814624 |
| 122 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.24330679 |
| 123 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.24269675 |
| 124 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.24261439 |
| 125 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.23975916 |
| 126 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.23377624 |
| 127 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.23332420 |
| 128 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.22951987 |
| 129 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.22944146 |
| 130 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.21989515 |
| 131 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.21969445 |
| 132 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19044160 |
| 133 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.18547437 |
| 134 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.18157018 |
| 135 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.18061659 |
| 136 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.17802550 |
| 137 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.17572991 |
| 138 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.17498418 |
| 139 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.17408884 |
| 140 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.17287874 |
| 141 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.16760183 |
| 142 | MYB_26560356_Chip-Seq_TH1_Human | 1.16751313 |
| 143 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.16393238 |
| 144 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.16218291 |
| 145 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.16043708 |
| 146 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.15702324 |
| 147 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.14668200 |
| 148 | GATA3_26560356_Chip-Seq_TH2_Human | 1.14563298 |
| 149 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.14509517 |
| 150 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.14272460 |
| 151 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13780944 |
| 152 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.13523218 |
| 153 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.12895206 |
| 154 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12804318 |
| 155 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.12305801 |
| 156 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.12058188 |
| 157 | GATA1_19941826_ChIP-Seq_K562_Human | 1.12002278 |
| 158 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.11780194 |
| 159 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.11780194 |
| 160 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.11409470 |
| 161 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.10343959 |
| 162 | AR_20517297_ChIP-Seq_VCAP_Human | 1.09983119 |
| 163 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.09502493 |
| 164 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.08643737 |
| 165 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.08562729 |
| 166 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08432077 |
| 167 | GATA2_19941826_ChIP-Seq_K562_Human | 1.08253198 |
| 168 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.07667239 |
| 169 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.07526581 |
| 170 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.06810815 |
| 171 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.06453063 |
| 172 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.06372198 |
| 173 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.06282755 |
| 174 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.06040425 |
| 175 | UTX_26944678_Chip-Seq_JUKART_Human | 1.05833304 |
| 176 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.05681295 |
| 177 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05675031 |
| 178 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04096017 |
| 179 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.00046529 |
| 180 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.98868335 |
| 181 | MYC_22102868_ChIP-Seq_BL_Human | 0.97605590 |
| 182 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.96507326 |
| 183 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.96202104 |
| 184 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95844828 |
| 185 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93800135 |
| 186 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.93757053 |
| 187 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.91211643 |
| 188 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.91211643 |
| 189 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.89740485 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 3.60378055 |
| 2 | MP0000569_abnormal_digit_pigmentation | 3.12141300 |
| 3 | MP0005360_urolithiasis | 2.90101134 |
| 4 | MP0008877_abnormal_DNA_methylation | 2.80468619 |
| 5 | MP0003787_abnormal_imprinting | 2.75829853 |
| 6 | MP0009840_abnormal_foam_cell | 2.74305967 |
| 7 | MP0005646_abnormal_pituitary_gland | 2.71534202 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.63239987 |
| 9 | MP0003303_peritoneal_inflammation | 2.61841925 |
| 10 | MP0002139_abnormal_hepatobiliary_system | 2.59789035 |
| 11 | MP0003172_abnormal_lysosome_physiology | 2.58555356 |
| 12 | MP0003191_abnormal_cellular_cholesterol | 2.58267422 |
| 13 | MP0003436_decreased_susceptibility_to | 2.55137486 |
| 14 | MP0000372_irregular_coat_pigmentation | 2.55071906 |
| 15 | MP0006082_CNS_inflammation | 2.27971772 |
| 16 | MP0004147_increased_porphyrin_level | 2.27563335 |
| 17 | MP0003705_abnormal_hypodermis_morpholog | 2.24963215 |
| 18 | MP0002419_abnormal_innate_immunity | 2.19515817 |
| 19 | MP0003300_gastrointestinal_ulcer | 2.18930588 |
| 20 | MP0005365_abnormal_bile_salt | 2.17533726 |
| 21 | MP0005075_abnormal_melanosome_morpholog | 2.02178743 |
| 22 | MP0005464_abnormal_platelet_physiology | 2.02085226 |
| 23 | MP0008057_abnormal_DNA_replication | 2.01048589 |
| 24 | MP0005257_abnormal_intraocular_pressure | 1.98901375 |
| 25 | MP0003122_maternal_imprinting | 1.92988507 |
| 26 | MP0005085_abnormal_gallbladder_physiolo | 1.89970813 |
| 27 | MP0003121_genomic_imprinting | 1.79026425 |
| 28 | MP0003252_abnormal_bile_duct | 1.77795336 |
| 29 | MP0004947_skin_inflammation | 1.75632557 |
| 30 | MP0005025_abnormal_response_to | 1.74802103 |
| 31 | MP0005000_abnormal_immune_tolerance | 1.74450146 |
| 32 | MP0001790_abnormal_immune_system | 1.74260106 |
| 33 | MP0005387_immune_system_phenotype | 1.74260106 |
| 34 | MP0002452_abnormal_antigen_presenting | 1.73312900 |
| 35 | MP0001986_abnormal_taste_sensitivity | 1.70579678 |
| 36 | MP0002909_abnormal_adrenal_gland | 1.69192688 |
| 37 | MP0010329_abnormal_lipoprotein_level | 1.66647332 |
| 38 | MP0000685_abnormal_immune_system | 1.65572495 |
| 39 | MP0003566_abnormal_cell_adhesion | 1.64679586 |
| 40 | MP0002148_abnormal_hypersensitivity_rea | 1.60904952 |
| 41 | MP0009785_altered_susceptibility_to | 1.60794973 |
| 42 | MP0001800_abnormal_humoral_immune | 1.60744519 |
| 43 | MP0010386_abnormal_urinary_bladder | 1.60619766 |
| 44 | MP0005083_abnormal_biliary_tract | 1.59756791 |
| 45 | MP0001533_abnormal_skeleton_physiology | 1.56401606 |
| 46 | MP0003724_increased_susceptibility_to | 1.56328863 |
| 47 | MP0006292_abnormal_olfactory_placode | 1.55443049 |
| 48 | MP0004043_abnormal_pH_regulation | 1.51901678 |
| 49 | MP0008438_abnormal_cutaneous_collagen | 1.51658020 |
| 50 | MP0003183_abnormal_peptide_metabolism | 1.49077768 |
| 51 | MP0002723_abnormal_immune_serum | 1.49002190 |
| 52 | MP0006054_spinal_hemorrhage | 1.47977700 |
| 53 | MP0005551_abnormal_eye_electrophysiolog | 1.44211265 |
| 54 | MP0009697_abnormal_copulation | 1.42507636 |
| 55 | MP0001984_abnormal_olfaction | 1.42034854 |
| 56 | MP0002138_abnormal_hepatobiliary_system | 1.41845304 |
| 57 | MP0001845_abnormal_inflammatory_respons | 1.40814923 |
| 58 | MP0005671_abnormal_response_to | 1.39101836 |
| 59 | MP0008875_abnormal_xenobiotic_pharmacok | 1.38795453 |
| 60 | MP0010234_abnormal_vibrissa_follicle | 1.38784764 |
| 61 | MP0001819_abnormal_immune_cell | 1.35594448 |
| 62 | MP0000609_abnormal_liver_physiology | 1.35371980 |
| 63 | MP0001764_abnormal_homeostasis | 1.33550719 |
| 64 | MP0002420_abnormal_adaptive_immunity | 1.32805704 |
| 65 | MP0010155_abnormal_intestine_physiology | 1.31959419 |
| 66 | MP0009278_abnormal_bone_marrow | 1.30735633 |
| 67 | MP0005253_abnormal_eye_physiology | 1.29174180 |
| 68 | MP0005379_endocrine/exocrine_gland_phen | 1.27933341 |
| 69 | MP0008469_abnormal_protein_level | 1.27929051 |
| 70 | MP0002638_abnormal_pupillary_reflex | 1.26417875 |
| 71 | MP0008789_abnormal_olfactory_epithelium | 1.23146859 |
| 72 | MP0002102_abnormal_ear_morphology | 1.22384380 |
| 73 | MP0000604_amyloidosis | 1.20853503 |
| 74 | MP0010352_gastrointestinal_tract_polyps | 1.20361051 |
| 75 | MP0002998_abnormal_bone_remodeling | 1.19290843 |
| 76 | MP0005076_abnormal_cell_differentiation | 1.19174849 |
| 77 | MP0000516_abnormal_urinary_system | 1.18973541 |
| 78 | MP0005367_renal/urinary_system_phenotyp | 1.18973541 |
| 79 | MP0002166_altered_tumor_susceptibility | 1.17798786 |
| 80 | MP0006072_abnormal_retinal_apoptosis | 1.16162825 |
| 81 | MP0004510_myositis | 1.15609816 |
| 82 | MP0002254_reproductive_system_inflammat | 1.15048330 |
| 83 | MP0009764_decreased_sensitivity_to | 1.14483573 |
| 84 | MP0010307_abnormal_tumor_latency | 1.13231650 |
| 85 | MP0002405_respiratory_system_inflammati | 1.12784455 |
| 86 | MP0000858_altered_metastatic_potential | 1.10706638 |
| 87 | MP0002009_preneoplasia | 1.10541966 |
| 88 | MP0001666_abnormal_nutrient_absorption | 1.10463792 |
| 89 | MP0003448_altered_tumor_morphology | 1.10295182 |
| 90 | MP0001853_heart_inflammation | 1.10001656 |
| 91 | MP0000383_abnormal_hair_follicle | 1.08756935 |
| 92 | MP0001958_emphysema | 1.08332868 |
| 93 | MP0002090_abnormal_vision | 1.07942798 |
| 94 | MP0002876_abnormal_thyroid_physiology | 1.06997464 |
| 95 | MP0005167_abnormal_blood-brain_barrier | 1.06586981 |
| 96 | MP0003453_abnormal_keratinocyte_physiol | 1.05769262 |
| 97 | MP0000427_abnormal_hair_cycle | 1.05175648 |
| 98 | MP0004185_abnormal_adipocyte_glucose | 1.04065573 |
| 99 | MP0005084_abnormal_gallbladder_morpholo | 1.02423971 |
| 100 | MP0001756_abnormal_urination | 1.02372186 |
| 101 | MP0005670_abnormal_white_adipose | 1.01463353 |
| 102 | MP0004130_abnormal_muscle_cell | 1.00149260 |
| 103 | MP0003091_abnormal_cell_migration | 0.99838796 |
| 104 | MP0001324_abnormal_eye_pigmentation | 0.99425504 |
| 105 | MP0005310_abnormal_salivary_gland | 0.99347114 |
| 106 | MP0005023_abnormal_wound_healing | 0.99221596 |
| 107 | MP0000631_abnormal_neuroendocrine_gland | 0.99142126 |
| 108 | MP0000343_altered_response_to | 0.99028141 |
| 109 | MP0000465_gastrointestinal_hemorrhage | 0.98580581 |
| 110 | MP0002118_abnormal_lipid_homeostasis | 0.97783734 |
| 111 | MP0003195_calcinosis | 0.97024051 |
| 112 | MP0000716_abnormal_immune_system | 0.96545864 |
| 113 | MP0001873_stomach_inflammation | 0.95271831 |
| 114 | MP0005174_abnormal_tail_pigmentation | 0.94546309 |
| 115 | MP0002837_dystrophic_cardiac_calcinosis | 0.94081205 |
| 116 | MP0009763_increased_sensitivity_to | 0.93764212 |
| 117 | MP0003690_abnormal_glial_cell | 0.93717833 |
| 118 | MP0003656_abnormal_erythrocyte_physiolo | 0.93690671 |
| 119 | MP0000371_diluted_coat_color | 0.92593251 |
| 120 | MP0009046_muscle_twitch | 0.89816183 |
| 121 | MP0000767_abnormal_smooth_muscle | 0.89403113 |
| 122 | MP0004019_abnormal_vitamin_homeostasis | 0.88821722 |
| 123 | MP0004782_abnormal_surfactant_physiolog | 0.88678555 |
| 124 | MP0000598_abnormal_liver_morphology | 0.88319527 |
| 125 | MP0008004_abnormal_stomach_pH | 0.88178945 |
| 126 | MP0001881_abnormal_mammary_gland | 0.87666344 |
| 127 | MP0009643_abnormal_urine_homeostasis | 0.86882596 |
| 128 | MP0003075_altered_response_to | 0.86804171 |
| 129 | MP0001915_intracranial_hemorrhage | 0.85809425 |
| 130 | MP0002229_neurodegeneration | 0.85614497 |
| 131 | MP0005166_decreased_susceptibility_to | 0.83910425 |
| 132 | MP0002006_tumorigenesis | 0.83580256 |
| 133 | MP0000689_abnormal_spleen_morphology | 0.83568594 |
| 134 | MP0010368_abnormal_lymphatic_system | 0.83170099 |
| 135 | MP0005647_abnormal_sex_gland | 0.82824764 |
| 136 | MP0002398_abnormal_bone_marrow | 0.82736461 |
| 137 | MP0004742_abnormal_vestibular_system | 0.82636820 |
| 138 | MP0005319_abnormal_enzyme/_coenzyme | 0.82417284 |
| 139 | MP0002136_abnormal_kidney_physiology | 0.82321356 |
| 140 | MP0000647_abnormal_sebaceous_gland | 0.82053453 |
| 141 | MP0002095_abnormal_skin_pigmentation | 0.81412304 |
| 142 | MP0001486_abnormal_startle_reflex | 0.81394108 |
| 143 | MP0005332_abnormal_amino_acid | 0.80633595 |
| 144 | MP0005397_hematopoietic_system_phenotyp | 0.79817510 |
| 145 | MP0001545_abnormal_hematopoietic_system | 0.79817510 |
| 146 | MP0002933_joint_inflammation | 0.79442014 |
| 147 | MP0004883_abnormal_blood_vessel | 0.78985982 |
| 148 | MP0006036_abnormal_mitochondrial_physio | 0.78920459 |
| 149 | MP0003011_delayed_dark_adaptation | 0.78834811 |
| 150 | MP0006276_abnormal_autonomic_nervous | 0.78702066 |
| 151 | MP0003718_maternal_effect | 0.78337962 |
| 152 | MP0005499_abnormal_olfactory_system | 0.77924383 |
| 153 | MP0005394_taste/olfaction_phenotype | 0.77924383 |
| 154 | MP0008872_abnormal_physiological_respon | 0.77717940 |
| 155 | MP0004142_abnormal_muscle_tone | 0.76327483 |
| 156 | MP0005389_reproductive_system_phenotype | 0.75560394 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 4.63536788 |
| 2 | Increased cerebral lipofuscin (HP:0011813) | 4.49067662 |
| 3 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.36529668 |
| 4 | Recurrent abscess formation (HP:0002722) | 4.17943851 |
| 5 | Eczematoid dermatitis (HP:0000976) | 4.11112762 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 4.06727019 |
| 7 | Vacuolated lymphocytes (HP:0001922) | 3.94801028 |
| 8 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.94064918 |
| 9 | Myocardial infarction (HP:0001658) | 3.47286247 |
| 10 | Dysostosis multiplex (HP:0000943) | 3.45329595 |
| 11 | Abnormality of macrophages (HP:0004311) | 3.41751991 |
| 12 | Complement deficiency (HP:0004431) | 3.41469454 |
| 13 | Glomerulonephritis (HP:0000099) | 3.40917589 |
| 14 | Mucopolysacchariduria (HP:0008155) | 3.32274301 |
| 15 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.32274301 |
| 16 | Pancreatic cysts (HP:0001737) | 3.31904592 |
| 17 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.27779062 |
| 18 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.27779062 |
| 19 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.27779062 |
| 20 | Autoimmune thrombocytopenia (HP:0001973) | 3.12210192 |
| 21 | Abnormality of complement system (HP:0005339) | 3.06033895 |
| 22 | Tetraparesis (HP:0002273) | 3.04785826 |
| 23 | Abnormality of glycolipid metabolism (HP:0010969) | 3.04371762 |
| 24 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.04371762 |
| 25 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.04371762 |
| 26 | Nephronophthisis (HP:0000090) | 2.97236074 |
| 27 | Abnormality of the prostate (HP:0008775) | 2.95270232 |
| 28 | Abnormal biliary tract physiology (HP:0012439) | 2.87592411 |
| 29 | Bile duct proliferation (HP:0001408) | 2.87592411 |
| 30 | Abnormality of the renal medulla (HP:0100957) | 2.87502007 |
| 31 | Axonal loss (HP:0003447) | 2.85019789 |
| 32 | Medial flaring of the eyebrow (HP:0010747) | 2.84608687 |
| 33 | Abnormality of the renal cortex (HP:0011035) | 2.84151400 |
| 34 | True hermaphroditism (HP:0010459) | 2.81250960 |
| 35 | Deep venous thrombosis (HP:0002625) | 2.81052847 |
| 36 | Periodontitis (HP:0000704) | 2.79347875 |
| 37 | Pancreatic fibrosis (HP:0100732) | 2.79214493 |
| 38 | Hematochezia (HP:0002573) | 2.78000387 |
| 39 | Xanthomatosis (HP:0000991) | 2.76347028 |
| 40 | Nephritis (HP:0000123) | 2.75748043 |
| 41 | Tubulointerstitial nephritis (HP:0001970) | 2.74489106 |
| 42 | Stomach cancer (HP:0012126) | 2.74262980 |
| 43 | Joint hemorrhage (HP:0005261) | 2.70823890 |
| 44 | Loss of speech (HP:0002371) | 2.70394021 |
| 45 | Gingivitis (HP:0000230) | 2.69594070 |
| 46 | Decreased central vision (HP:0007663) | 2.66818167 |
| 47 | Abolished electroretinogram (ERG) (HP:0000550) | 2.65463323 |
| 48 | Congenital hepatic fibrosis (HP:0002612) | 2.64114944 |
| 49 | Cerebral aneurysm (HP:0004944) | 2.62627217 |
| 50 | Recurrent skin infections (HP:0001581) | 2.57994656 |
| 51 | Esophageal varix (HP:0002040) | 2.57555283 |
| 52 | Disinhibition (HP:0000734) | 2.56496146 |
| 53 | Abnormality of midbrain morphology (HP:0002418) | 2.54603233 |
| 54 | Molar tooth sign on MRI (HP:0002419) | 2.54603233 |
| 55 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.54494393 |
| 56 | Renal cortical cysts (HP:0000803) | 2.53172426 |
| 57 | Hyperventilation (HP:0002883) | 2.49398099 |
| 58 | Abnormality of macular pigmentation (HP:0008002) | 2.49328354 |
| 59 | Thyroiditis (HP:0100646) | 2.48801363 |
| 60 | Abnormality of B cell number (HP:0010975) | 2.48668543 |
| 61 | Bone pain (HP:0002653) | 2.45360876 |
| 62 | Thin bony cortex (HP:0002753) | 2.44226277 |
| 63 | Gingival bleeding (HP:0000225) | 2.43549356 |
| 64 | Panhypogammaglobulinemia (HP:0003139) | 2.43511009 |
| 65 | Upper motor neuron abnormality (HP:0002127) | 2.43066489 |
| 66 | Nephrogenic diabetes insipidus (HP:0009806) | 2.38008858 |
| 67 | Mediastinal lymphadenopathy (HP:0100721) | 2.37929296 |
| 68 | Hypothermia (HP:0002045) | 2.35723851 |
| 69 | Pustule (HP:0200039) | 2.33536436 |
| 70 | Recurrent fungal infections (HP:0002841) | 2.32904025 |
| 71 | Osteolytic defects of the hand bones (HP:0009699) | 2.30210159 |
| 72 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.30210159 |
| 73 | Mutism (HP:0002300) | 2.27884817 |
| 74 | Tubulointerstitial abnormality (HP:0001969) | 2.27662513 |
| 75 | Abnormality of the common coagulation pathway (HP:0010990) | 2.26690489 |
| 76 | Hypercholesterolemia (HP:0003124) | 2.24711631 |
| 77 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.24572769 |
| 78 | Widely spaced teeth (HP:0000687) | 2.24409440 |
| 79 | Interstitial pulmonary disease (HP:0006530) | 2.21823358 |
| 80 | Myositis (HP:0100614) | 2.21728869 |
| 81 | Abnormality of the labia minora (HP:0012880) | 2.19132212 |
| 82 | Hydroxyprolinuria (HP:0003080) | 2.19024396 |
| 83 | Abnormality of proline metabolism (HP:0010907) | 2.19024396 |
| 84 | Pathologic fracture (HP:0002756) | 2.18581629 |
| 85 | Absent/shortened dynein arms (HP:0200106) | 2.16796402 |
| 86 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.16796402 |
| 87 | Congenital primary aphakia (HP:0007707) | 2.16538611 |
| 88 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.16401519 |
| 89 | Epidermoid cyst (HP:0200040) | 2.15568877 |
| 90 | Intrahepatic cholestasis (HP:0001406) | 2.14613423 |
| 91 | B lymphocytopenia (HP:0010976) | 2.14355272 |
| 92 | Aortic aneurysm (HP:0004942) | 2.13159467 |
| 93 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.11088745 |
| 94 | Retinal atrophy (HP:0001105) | 2.08261425 |
| 95 | Gait imbalance (HP:0002141) | 2.06144445 |
| 96 | Orchitis (HP:0100796) | 2.05269075 |
| 97 | Menorrhagia (HP:0000132) | 2.04526530 |
| 98 | Prostate neoplasm (HP:0100787) | 2.03973848 |
| 99 | Cystic liver disease (HP:0006706) | 2.02290133 |
| 100 | Hyperlipoproteinemia (HP:0010980) | 2.01941503 |
| 101 | Recurrent viral infections (HP:0004429) | 2.01937137 |
| 102 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.99509901 |
| 103 | Urticaria (HP:0001025) | 1.97636802 |
| 104 | Hypoalphalipoproteinemia (HP:0003233) | 1.96852480 |
| 105 | Osteomyelitis (HP:0002754) | 1.96393921 |
| 106 | Arterial thrombosis (HP:0004420) | 1.96014586 |
| 107 | Peripheral demyelination (HP:0011096) | 1.95348788 |
| 108 | Attenuation of retinal blood vessels (HP:0007843) | 1.95226985 |
| 109 | Thoracic kyphosis (HP:0002942) | 1.94529037 |
| 110 | Methylmalonic acidemia (HP:0002912) | 1.94465617 |
| 111 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.94054839 |
| 112 | Abnormal drinking behavior (HP:0030082) | 1.93951699 |
| 113 | Polydipsia (HP:0001959) | 1.93951699 |
| 114 | Mitral stenosis (HP:0001718) | 1.93665833 |
| 115 | Genital tract atresia (HP:0001827) | 1.93597464 |
| 116 | Obstructive lung disease (HP:0006536) | 1.93021573 |
| 117 | Chronic obstructive pulmonary disease (HP:0006510) | 1.93021573 |
| 118 | Volvulus (HP:0002580) | 1.92944812 |
| 119 | Global brain atrophy (HP:0002283) | 1.91882835 |
| 120 | Abnormality of the lumbar spine (HP:0100712) | 1.91653370 |
| 121 | Vaginal atresia (HP:0000148) | 1.90984246 |
| 122 | Spontaneous hematomas (HP:0007420) | 1.89988284 |
| 123 | Stomatitis (HP:0010280) | 1.88950207 |
| 124 | Optic neuritis (HP:0100653) | 1.88898613 |
| 125 | Retrobulbar optic neuritis (HP:0100654) | 1.88898613 |
| 126 | Sex reversal (HP:0012245) | 1.88804994 |
| 127 | Abnormal sex determination (HP:0012244) | 1.88804994 |
| 128 | Colon cancer (HP:0003003) | 1.86858014 |
| 129 | Colitis (HP:0002583) | 1.86438595 |
| 130 | Peritonitis (HP:0002586) | 1.85494494 |
| 131 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.84102391 |
| 132 | Vasculitis (HP:0002633) | 1.83572865 |
| 133 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.83064802 |
| 134 | Recurrent cutaneous fungal infections (HP:0011370) | 1.83064802 |
| 135 | Congenital stationary night blindness (HP:0007642) | 1.82870510 |
| 136 | Median cleft lip (HP:0000161) | 1.82631895 |
| 137 | Progressive inability to walk (HP:0002505) | 1.82587330 |
| 138 | Autoimmune hemolytic anemia (HP:0001890) | 1.82153465 |
| 139 | Macular degeneration (HP:0000608) | 1.80747568 |
| 140 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.80165332 |
| 141 | Cellulitis (HP:0100658) | 1.79900244 |
| 142 | Hepatosplenomegaly (HP:0001433) | 1.79424408 |
| 143 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.79328328 |
| 144 | Basal ganglia calcification (HP:0002135) | 1.79234906 |
| 145 | Chronic hepatic failure (HP:0100626) | 1.77931735 |
| 146 | Postaxial foot polydactyly (HP:0001830) | 1.77880730 |
| 147 | Chronic otitis media (HP:0000389) | 1.77828917 |
| 148 | Ketosis (HP:0001946) | 1.77411142 |
| 149 | Aortic dissection (HP:0002647) | 1.76840080 |
| 150 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.76387553 |
| 151 | Amyloidosis (HP:0011034) | 1.76304839 |
| 152 | Azoospermia (HP:0000027) | 1.76055503 |
| 153 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.75995205 |
| 154 | Vertebral compression fractures (HP:0002953) | 1.75165000 |
| 155 | Conjunctival telangiectasia (HP:0000524) | 1.74824649 |
| 156 | Prolonged partial thromboplastin time (HP:0003645) | 1.74538094 |
| 157 | Male pseudohermaphroditism (HP:0000037) | 1.74505249 |
| 158 | Skin nodule (HP:0200036) | 1.73409787 |
| 159 | Inability to walk (HP:0002540) | 1.72101470 |
| 160 | Supernumerary spleens (HP:0009799) | 1.71454514 |
| 161 | Agammaglobulinemia (HP:0004432) | 1.70588386 |
| 162 | Fair hair (HP:0002286) | 1.70536186 |
| 163 | Thick nail (HP:0001805) | 1.70470277 |
| 164 | Abnormal platelet function (HP:0011869) | 1.70074545 |
| 165 | Impaired platelet aggregation (HP:0003540) | 1.70074545 |
| 166 | Epistaxis (HP:0000421) | 1.69736051 |
| 167 | Recurrent sinusitis (HP:0011108) | 1.69431493 |
| 168 | Ketoacidosis (HP:0001993) | 1.69193206 |
| 169 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.69104488 |
| 170 | Long nose (HP:0003189) | 1.69006686 |
| 171 | Metaphyseal irregularity (HP:0003025) | 1.68949679 |
| 172 | Tubulointerstitial fibrosis (HP:0005576) | 1.68501583 |
| 173 | Abnormal spermatogenesis (HP:0008669) | 1.68014366 |
| 174 | Abnormality of male internal genitalia (HP:0000022) | 1.67314444 |
| 175 | Gaze-evoked nystagmus (HP:0000640) | 1.67132631 |
| 176 | Postaxial hand polydactyly (HP:0001162) | 1.66235267 |
| 177 | Hip dysplasia (HP:0001385) | 1.66218541 |
| 178 | Inappropriate behavior (HP:0000719) | 1.66159167 |
| 179 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.65306868 |
| 180 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.65306868 |
| 181 | IgM deficiency (HP:0002850) | 1.64530497 |
| 182 | Congenital, generalized hypertrichosis (HP:0004540) | 1.64388392 |
| 183 | Alveolar cell carcinoma (HP:0006519) | 1.64055852 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K2 | 3.43009518 |
| 2 | TGFBR2 | 3.18760140 |
| 3 | ERN1 | 2.85376549 |
| 4 | TRIB3 | 2.84761472 |
| 5 | ACVR1B | 2.59781721 |
| 6 | TBK1 | 2.52545406 |
| 7 | TYK2 | 2.50364387 |
| 8 | PKN2 | 2.47527395 |
| 9 | PTK6 | 2.47088199 |
| 10 | BLK | 2.43713669 |
| 11 | BMPR1B | 2.42854482 |
| 12 | FES | 2.35883206 |
| 13 | MAP3K14 | 2.32014632 |
| 14 | SIK1 | 2.22686603 |
| 15 | CAMK1D | 2.20533911 |
| 16 | CDK12 | 2.17454004 |
| 17 | KIT | 2.09850152 |
| 18 | ERBB3 | 2.07839003 |
| 19 | MAP4K1 | 1.96845154 |
| 20 | NUAK1 | 1.93638524 |
| 21 | TAOK3 | 1.89969914 |
| 22 | PINK1 | 1.88399814 |
| 23 | FER | 1.85853191 |
| 24 | WNK3 | 1.85481304 |
| 25 | JAK1 | 1.83715344 |
| 26 | TNIK | 1.76140774 |
| 27 | RIPK4 | 1.74340925 |
| 28 | FGFR4 | 1.70212229 |
| 29 | ZAK | 1.66731357 |
| 30 | ADRBK2 | 1.65265310 |
| 31 | NEK9 | 1.65066023 |
| 32 | IRAK3 | 1.60679584 |
| 33 | OXSR1 | 1.60614508 |
| 34 | MAPK13 | 1.58552087 |
| 35 | MAP3K13 | 1.54796421 |
| 36 | JAK3 | 1.52209370 |
| 37 | PAK4 | 1.51929663 |
| 38 | CSF1R | 1.50685011 |
| 39 | STK10 | 1.50035286 |
| 40 | ZAP70 | 1.45719041 |
| 41 | CAMK1G | 1.43532642 |
| 42 | EIF2AK3 | 1.42763308 |
| 43 | TTN | 1.41158948 |
| 44 | CSK | 1.40385278 |
| 45 | IRAK4 | 1.36238592 |
| 46 | FGFR3 | 1.34352180 |
| 47 | ITK | 1.30563281 |
| 48 | PIK3CA | 1.29443847 |
| 49 | IKBKB | 1.29273772 |
| 50 | IKBKE | 1.23792294 |
| 51 | HCK | 1.23706710 |
| 52 | GRK1 | 1.23090464 |
| 53 | STK39 | 1.22761948 |
| 54 | FGFR2 | 1.19096687 |
| 55 | EPHB1 | 1.18965337 |
| 56 | MKNK1 | 1.18478934 |
| 57 | TXK | 1.18399476 |
| 58 | BTK | 1.18005428 |
| 59 | MKNK2 | 1.17813402 |
| 60 | TRPM7 | 1.16811427 |
| 61 | CHUK | 1.14152807 |
| 62 | JAK2 | 1.12268485 |
| 63 | CDK6 | 1.10683000 |
| 64 | LRRK2 | 1.07304550 |
| 65 | MAP3K10 | 1.06483559 |
| 66 | RPS6KA4 | 1.05025967 |
| 67 | RIPK1 | 1.04089585 |
| 68 | MST1R | 1.03352125 |
| 69 | BMPR2 | 1.02554484 |
| 70 | NLK | 1.01902127 |
| 71 | MAPKAPK3 | 1.01664184 |
| 72 | STK3 | 1.00889198 |
| 73 | INSRR | 1.00462169 |
| 74 | LATS1 | 0.98243579 |
| 75 | TIE1 | 0.98125478 |
| 76 | CAMKK2 | 0.97445751 |
| 77 | GRK7 | 0.97297394 |
| 78 | DAPK2 | 0.97165603 |
| 79 | PLK2 | 0.96394323 |
| 80 | MST4 | 0.95261006 |
| 81 | MAP3K4 | 0.94643407 |
| 82 | CSNK1G2 | 0.94450055 |
| 83 | PDGFRA | 0.92599764 |
| 84 | PRKCE | 0.91036455 |
| 85 | MAP2K3 | 0.90939749 |
| 86 | VRK1 | 0.87542664 |
| 87 | FRK | 0.87203749 |
| 88 | STK38L | 0.82995305 |
| 89 | LYN | 0.82577643 |
| 90 | FLT3 | 0.82349547 |
| 91 | LCK | 0.82225697 |
| 92 | EPHA3 | 0.79642349 |
| 93 | EPHA2 | 0.79269591 |
| 94 | MARK3 | 0.78087671 |
| 95 | IRAK1 | 0.77590197 |
| 96 | TEC | 0.77175263 |
| 97 | SYK | 0.76882245 |
| 98 | BRSK2 | 0.75103300 |
| 99 | EGFR | 0.74844096 |
| 100 | AKT3 | 0.74523658 |
| 101 | PIK3CG | 0.74033983 |
| 102 | TRIM28 | 0.73875428 |
| 103 | STK4 | 0.73869816 |
| 104 | TGFBR1 | 0.72503117 |
| 105 | MAP2K7 | 0.72039287 |
| 106 | PIM1 | 0.71604532 |
| 107 | CSNK1A1L | 0.70842708 |
| 108 | PBK | 0.70829156 |
| 109 | MATK | 0.69732674 |
| 110 | PLK4 | 0.68743317 |
| 111 | MAPKAPK5 | 0.68741006 |
| 112 | PDGFRB | 0.68289922 |
| 113 | BRD4 | 0.67698781 |
| 114 | PRKCQ | 0.67598044 |
| 115 | CSNK1G3 | 0.66671155 |
| 116 | PRKAA2 | 0.65412102 |
| 117 | PRKG2 | 0.64405069 |
| 118 | BCR | 0.64231330 |
| 119 | EEF2K | 0.64170773 |
| 120 | STK24 | 0.63345097 |
| 121 | ABL1 | 0.61697676 |
| 122 | SIK2 | 0.61040055 |
| 123 | PTK2 | 0.59259064 |
| 124 | MAP2K4 | 0.59095040 |
| 125 | CSNK1G1 | 0.58344553 |
| 126 | PRKACB | 0.58118735 |
| 127 | BMX | 0.57711685 |
| 128 | SGK3 | 0.57608799 |
| 129 | IGF1R | 0.56063248 |
| 130 | MTOR | 0.55720618 |
| 131 | TNK2 | 0.55323647 |
| 132 | FGR | 0.54079705 |
| 133 | CSNK1A1 | 0.53171820 |
| 134 | SCYL2 | 0.51047236 |
| 135 | DYRK2 | 0.50222926 |
| 136 | GSK3A | 0.50129002 |
| 137 | ERBB4 | 0.47792830 |
| 138 | CCNB1 | 0.47576815 |
| 139 | PLK3 | 0.47462501 |
| 140 | PRKCH | 0.46360756 |
| 141 | NEK6 | 0.46281071 |
| 142 | CSNK1D | 0.45587904 |
| 143 | MAPK11 | 0.44153094 |
| 144 | ERBB2 | 0.42499548 |
| 145 | PDPK1 | 0.42275116 |
| 146 | MAP2K6 | 0.42199867 |
| 147 | MAPK15 | 0.42125741 |
| 148 | ABL2 | 0.41882462 |
| 149 | STK11 | 0.41473488 |
| 150 | MAP3K8 | 0.40840919 |
| 151 | GRK6 | 0.40736839 |
| 152 | PRKACA | 0.40440895 |
| 153 | PRKG1 | 0.39908453 |
| 154 | KDR | 0.39370426 |
| 155 | PDK1 | 0.39023920 |
| 156 | MAPKAPK2 | 0.39009782 |
| 157 | SRC | 0.36138956 |
| 158 | PAK2 | 0.36078210 |
| 159 | INSR | 0.35198991 |
| 160 | MAP3K3 | 0.33944874 |
| 161 | FYN | 0.33030222 |
| 162 | CDK9 | 0.32780980 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Asthma_Homo sapiens_hsa05310 | 4.25879429 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.54857291 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.69727083 |
| 4 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.65335394 |
| 5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.45461057 |
| 6 | Lysosome_Homo sapiens_hsa04142 | 2.38522054 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.28501122 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.19744858 |
| 9 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.14555751 |
| 10 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.05339223 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.99379553 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 1.96942990 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.86211838 |
| 14 | Phototransduction_Homo sapiens_hsa04744 | 1.85936783 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.82554113 |
| 16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.81219593 |
| 17 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.80731922 |
| 18 | Other glycan degradation_Homo sapiens_hsa00511 | 1.78573895 |
| 19 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.70145832 |
| 20 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.61899728 |
| 21 | Protein export_Homo sapiens_hsa03060 | 1.60798074 |
| 22 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.52211631 |
| 23 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.46048942 |
| 24 | Pertussis_Homo sapiens_hsa05133 | 1.45648943 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.41490578 |
| 26 | Homologous recombination_Homo sapiens_hsa03440 | 1.40351908 |
| 27 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.38754733 |
| 28 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.38125266 |
| 29 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.33868858 |
| 30 | Malaria_Homo sapiens_hsa05144 | 1.33474854 |
| 31 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.32926596 |
| 32 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.32513913 |
| 33 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.30773253 |
| 34 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.26159833 |
| 35 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.25623254 |
| 36 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.23292035 |
| 37 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.22843865 |
| 38 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.22565429 |
| 39 | Legionellosis_Homo sapiens_hsa05134 | 1.20862642 |
| 40 | Lysine degradation_Homo sapiens_hsa00310 | 1.19372568 |
| 41 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.18783449 |
| 42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.18546167 |
| 43 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.18288847 |
| 44 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.17997898 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 1.16028547 |
| 46 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.15279600 |
| 47 | Measles_Homo sapiens_hsa05162 | 1.13844763 |
| 48 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.11486222 |
| 49 | Phagosome_Homo sapiens_hsa04145 | 1.07638762 |
| 50 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.07632545 |
| 51 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.07233862 |
| 52 | Histidine metabolism_Homo sapiens_hsa00340 | 1.04298678 |
| 53 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.03016942 |
| 54 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.03002207 |
| 55 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.01954053 |
| 56 | Apoptosis_Homo sapiens_hsa04210 | 0.99933646 |
| 57 | Influenza A_Homo sapiens_hsa05164 | 0.99409838 |
| 58 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.98674584 |
| 59 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.97916952 |
| 60 | RNA degradation_Homo sapiens_hsa03018 | 0.97107473 |
| 61 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.96272735 |
| 62 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.95839256 |
| 63 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.95305269 |
| 64 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.95070774 |
| 65 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.94580435 |
| 66 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.93876838 |
| 67 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.92327073 |
| 68 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.91211683 |
| 69 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.90857062 |
| 70 | Amoebiasis_Homo sapiens_hsa05146 | 0.90474823 |
| 71 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.89717581 |
| 72 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.88268166 |
| 73 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.88114341 |
| 74 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.86768020 |
| 75 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.84542939 |
| 76 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.83250578 |
| 77 | Insulin resistance_Homo sapiens_hsa04931 | 0.81715003 |
| 78 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.81551289 |
| 79 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.81290195 |
| 80 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.81238985 |
| 81 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.80095546 |
| 82 | Hepatitis C_Homo sapiens_hsa05160 | 0.79842071 |
| 83 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.79226930 |
| 84 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.79149653 |
| 85 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.78432364 |
| 86 | Peroxisome_Homo sapiens_hsa04146 | 0.77637787 |
| 87 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.76916571 |
| 88 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.76308922 |
| 89 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.75701865 |
| 90 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.75155264 |
| 91 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.73574761 |
| 92 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.73401832 |
| 93 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.73186147 |
| 94 | Bile secretion_Homo sapiens_hsa04976 | 0.72535270 |
| 95 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.70252809 |
| 96 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.70125797 |
| 97 | Shigellosis_Homo sapiens_hsa05131 | 0.69610310 |
| 98 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.68718691 |
| 99 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.67605044 |
| 100 | Hepatitis B_Homo sapiens_hsa05161 | 0.67194875 |
| 101 | Salmonella infection_Homo sapiens_hsa05132 | 0.65758161 |
| 102 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.65702487 |
| 103 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.64802372 |
| 104 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.64023097 |
| 105 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.63984177 |
| 106 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.63637862 |
| 107 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.62189556 |
| 108 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.61855303 |
| 109 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.61759978 |
| 110 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.61118607 |
| 111 | Retinol metabolism_Homo sapiens_hsa00830 | 0.60876843 |
| 112 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.60743045 |
| 113 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.60319060 |
| 114 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.59674060 |
| 115 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.59141917 |
| 116 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.58884289 |
| 117 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.58210963 |
| 118 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.56767653 |
| 119 | Prion diseases_Homo sapiens_hsa05020 | 0.56649803 |
| 120 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.56605140 |
| 121 | Platelet activation_Homo sapiens_hsa04611 | 0.54741869 |
| 122 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.54728254 |
| 123 | Allograft rejection_Homo sapiens_hsa05330 | 0.53463423 |
| 124 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.51795923 |
| 125 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.51770437 |
| 126 | Adherens junction_Homo sapiens_hsa04520 | 0.50712083 |
| 127 | Focal adhesion_Homo sapiens_hsa04510 | 0.50524741 |
| 128 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.50173872 |
| 129 | Olfactory transduction_Homo sapiens_hsa04740 | 0.50060230 |
| 130 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.49748639 |
| 131 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.48719628 |
| 132 | Mineral absorption_Homo sapiens_hsa04978 | 0.47149555 |
| 133 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.46665800 |
| 134 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.46564905 |
| 135 | Viral myocarditis_Homo sapiens_hsa05416 | 0.46409246 |
| 136 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.45771062 |
| 137 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.45547596 |
| 138 | Circadian rhythm_Homo sapiens_hsa04710 | 0.44891333 |
| 139 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.44423915 |
| 140 | Parkinsons disease_Homo sapiens_hsa05012 | 0.43084423 |
| 141 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.40902213 |
| 142 | Nicotine addiction_Homo sapiens_hsa05033 | 0.40569370 |
| 143 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.39596880 |
| 144 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.38928447 |
| 145 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.36199178 |
| 146 | Basal transcription factors_Homo sapiens_hsa03022 | 0.35465953 |
| 147 | Taste transduction_Homo sapiens_hsa04742 | 0.35384491 |
| 148 | Renin secretion_Homo sapiens_hsa04924 | 0.34040555 |

